Literature DB >> 10165464

Cost-utility analysis from a societal perspective.

M Johannesson1, R M O'Conor.   

Abstract

In this paper, we outline how to use cost-utility analysis from a societal perspective and the arguments that could be made for using data such as a model for economic evaluation of health care. We show that to include all the costs in the analysis, a price per quality-adjusted life years (QALY) gained rather than a given budget should be used as the decision rule. Using cost-utility analysis this way is based on a willingness to pay per QALY gained that is constant and the same for everyone. To use a fixed price per QALY gained is consistent with societal utility maximization if aggregated QALYs are a measure of societal utility and if the mix of financing sources is the same for all health care programmes. If, furthermore, the price per QALY gained is set at the optimal level, cost-utility analysis will lead to a maximization of societal utility. To get more information on the willingness to pay per QALY gained so as to provide cost-utility analysis with a useful decision rule should be a research priority.

Mesh:

Year:  1997        PMID: 10165464     DOI: 10.1016/s0168-8510(96)00878-0

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  9 in total

Review 1.  Willingness to pay for a QALY: theoretical and methodological issues.

Authors:  Dorte Gyrd-Hansen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study.

Authors:  Mark Sculpher; David Millson; David Meddis; Lynne Poole
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Pharmacoeconomic analysis in Saudi Arabia: an overdue agenda item for action.

Authors:  Abdulrazaq S Al-Jazairi; Nada S Al-Qadheeb; Aziza Ajlan
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526

4.  Cost effectiveness of disc prosthesis versus lumbar fusion in patients with chronic low back pain: randomized controlled trial with 2-year follow-up.

Authors:  Peter Fritzell; Svante Berg; Fredrik Borgström; Tycho Tullberg; Hans Tropp
Journal:  Eur Spine J       Date:  2010-11-05       Impact factor: 3.134

5.  A review of management of infertility in Nigeria: framing the ethics of a national health policy.

Authors:  Oluyemi Akinloye; Ernest J Truter
Journal:  Int J Womens Health       Date:  2011-08-11

Review 6.  Economic evaluations of guideline-based or strategic interventions for the prevention or treatment of chronic wounds.

Authors:  Marissa J Carter
Journal:  Appl Health Econ Health Policy       Date:  2014-08       Impact factor: 2.561

7.  Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations.

Authors:  Helen Dakin; Alastair Gray
Journal:  Stat Med       Date:  2017-05-03       Impact factor: 2.373

8.  Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions.

Authors:  Helen Dakin; Alastair Gray
Journal:  Med Decis Making       Date:  2018-05       Impact factor: 2.583

9.  Prioritising, Ranking and Resource Implementation - A Normative Analysis.

Authors:  Lars Sandman
Journal:  Int J Health Policy Manag       Date:  2018-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.